Ascend Advanced Therapies

In a recent chat with our CSO, Markus Hörer, we outlined the importance of AAV process comparability throughout #genetherapy #development. Building processes that are comparable across all scales from R&D through commercial manufacturing from the start simplifies #commercialization. Read the full blog here: https://lnkd.in/eA4KCE9e

What a week with our team in Edinburgh at the ESACT - European Society for Animal Cell Technology Congress digging in to the latest progress in #genetherapy. Stay tuned because we'll take a look back on our adventures there next week. But just in case you missed us onsite or did not make the event at all, we thought we'd share a little about who we are! https://lnkd.in/gWE6ebFe Reach out to chat #innovation any time here or via business@ascend-adv.com.

Have you been wondering how to optimize your rAAV production? And you're at ESACT - European Society for Animal Cell Technology? Check out poster 291 from Johanna Wagner, PhD to learn more. You may even meet the hype team (and our Sunday presenters, Ahmed Youssef and Markus Hörer), too!

Did you start your week in #Edinburgh at the ESACT - European Society for Animal Cell Technology Congress? A handful of our team started with #genetherapy presentations yesterday. And for the duration of the event, check out Johanna Wagner, PhD presenting poster 291 on the impact of the N-1 seed train on rAAV production #efficiency. Missed a presentation or poster, or maybe the whole event? That's okay! We are available at business@ascend-adv.com any time.

Happy Friday! The ESACT - European Society for Animal Cell Technology Congress is just around the corner now. Come see our CSO, Markus Hörer discussing "Transitioning Advanced Therapies from Research to Development and #Manufacturing - What Have We Learned About Developability?" with Boehringer Ingelheim on Sunday, June 23 at 1:00. Can't make it to the talk? No worries! We're always accessible to chat #genetherapy via DM or business@ascend-adv.com.

The clock is ticking towards the ESACT - European Society for Animal Cell Technology Congress starting this Sunday, June 23 in #Edinburgh, Scotland! Ahmed Youssef will be onsite helping to invigorate day one with a talk about #genetherapy #commercialization hosted by Sartorius at 1:30pm. Looking to connect, or can't make it to the talk and want the highlights? We are always accessible at business@ascend-adv.com or by DM to follow up.

It is hard to believe that the official start of #summer is just around the corner now! And so is the ESACT - European Society for Animal Cell Technology Congress from 23 to 26 June in #Edinburgh. We are looking forward to joining the event, participating in two #genetherapy discussions on Sunday, June 23rd, and presenting a #poster on Optimizing rAAV vectors! Back with more specifics on our presentations through the week. Hope to see you there!

The Cell & Gene by Oxford Global #GeneTherapy 2024 Congress started today, and what a day it has been full of information and connections. Looking forward to closing out the week strong here in #London!

Happening this week! Cell & Gene by Oxford Global is hosting the #GeneTherapy #Development Congress in #London. Our own Jason King will be onsite and ready to talk AAV this Thursday and Friday (13-14 June). https://lnkd.in/gcsme6Bw

How do you ensure your #genetherapy product quality is on target? You use the latest #analytics to measure and gain a better understanding of the product profile.   One of our posters from American Society of Gene & Cell Therapy covers this topic, and how we use some of the latest scientific advances to gain process data that helps optimize your products.   https://lnkd.in/eSE9QjgD